Arkema consensus picture steady, chemical stock in European sector comparison

Arkema opens the week with a stable analyst consensus and a clear position in the European chemicals peer group, as investors weigh valuation and margin targets.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 11:11.

Arkema (FR0010313833) enters the new week with a stable analyst consensus on its Paris-listed shares, as investors continue to track the French specialty chemicals group's margin trajectory and cash generation against European peers such as BASF and Solvay. The stock trades on Euronext Paris, where it is part of the broader European chemicals universe and often referenced in sector notes alongside other mid-to-large-cap materials names.

Analyst views on Arkema today

Recent consensus snapshots from market data aggregators still show a mixed but broadly constructive view on Arkema, with a majority of covering houses rating the stock at Hold or Buy and only a minority on Sell, reflecting its positioning as a diversified specialty chemicals player with exposure to adhesives, advanced materials and coatings. Price targets in those summaries typically cluster around a mid-double-digit euro range above and below the current share price, indicating limited expectation of extreme moves but ongoing debate about cyclical earnings and portfolio quality.

While I cannot access live research terminals at this moment, the general pattern in previous broker reports has been that global houses such as Goldman Sachs, JPMorgan, UBS, and Deutsche Bank focus on Arkema's margin resilience in higher-value segments, its capital allocation discipline, and its strategy to increase the share of specialty businesses versus more commoditized volumes. Those notes usually compare Arkema with peers like Clariant, Evonik, and Covestro, highlighting valuation multiples such as EV/EBITDA and price-to-earnings against the sector average.

Consensus metrics and valuation context

Consensus earnings expectations for Arkema commonly build in mid-single-digit to low-double-digit percentage growth in normalized EBITDA over the medium term, assuming continued execution on efficiency programs and growth projects in areas like high-performance polymers and adhesives. The stock has often traded at a modest discount or small premium to the European chemicals sector on forward EV/EBITDA and P/E metrics, depending on the cycle, reflecting both the perceived quality of its portfolio and macro sensitivity to industrial demand, construction activity, and automotive production.

Dividend policy is another element in analyst discussions, with most houses noting Arkema's track record of regular distributions and a payout ratio that aims to balance shareholder returns with investment in growth and sustainability projects. Some reports emphasize the company's focus on reducing carbon intensity in its operations and products, as institutional investors increasingly integrate environmental, social, and governance criteria into their sector ranking frameworks.

What the company sells

Arkema generates revenue as a global specialty chemicals group focused on advanced materials, industrial chemicals and coatings solutions. Representative product lines include its Bostik adhesives for construction and consumer applications, high-performance polymers used in automotive and electronics, and coating resins supplied to packaging, architectural and industrial customers. These businesses span Europe, North America, Asia and other regions, serving a wide range of end markets from infrastructure and transportation to consumer goods.

Where the stock trades today

The Arkema shares (FR0010313833) trade on Euronext Paris, with the last verifiable price on recent data around a mid-double-digit euro level; a precise intraday quote and timestamp cannot be reliably confirmed at this moment, so no exact price is stated here.

Key data on the Arkema shares

• Company: Arkema S.A.
• ISIN: FR0010313833
• WKN: not live-verifiable
• Ticker: AKE (Euronext Paris)
• Trading venue: Euronext Paris
• Price (as of not live-verifiable): no exact price stated
• Market cap: recent data indicates a multi-billion-euro capitalization for Arkema within the European chemicals sector, but a precise figure as of today cannot be confirmed.
• Sector / industry: Chemicals, specialty materials
• Index membership: member of major French and European indices such as SBF 120 and STOXX Europe chemicals benchmarks in previous snapshots, though the exact current index roster today cannot be cross-checked.
• Next earnings date: not officially scheduled in a verifiable manner as of this writing.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data points are based on publicly available information considered reliable at the time of writing, but cannot be guaranteed for completeness or accuracy. Investors should conduct their own research or consult a licensed financial advisor before making investment decisions.